Pen Needles Market to Hit $4.5 Mn, Globally, by 2032 at 10.3%

The global pen needles market was valued at $1.7 billion in 2022, and is projected to reach $4.5 million by 2032, registering a CAGR of 10.3% from 2023 to 2032. 

Request Sample Copy of Report: 

https://www.alliedmarketresearch.com/request-sample/3581

Key Takeaways:

  • Growth in Diabetes Prevalence: The demand for pen needles is driven by the increasing global prevalence of diabetes. As more individuals are diagnosed with diabetes, the need for efficient and user-friendly insulin delivery devices like pen needles has risen.
  • Convenience and Ease of Use: Pen needles offer a convenient and easy-to-use method for administering insulin. They are particularly favored by patients who require multiple daily injections, as they provide a less intrusive and more discreet option compared to traditional syringes.
  • Technological Advancements: The pen needles market has seen continuous technological advancements. These include features such as ultra-fine needles for reduced pain and variability in needle lengths to accommodate different patient preferences and body types.
  • Variety of Needle Gauges and Lengths: Pen needles come in various gauges (thickness) and lengths. Thinner needles are generally preferred as they cause less discomfort, while different lengths cater to individuals with varying body sizes.
  • Increasing Focus on Safety: Safety features in pen needles have gained importance. Some pen needles come with features like built-in needle shields or automatic retraction to minimize the risk of accidental needlestick injuries.

Market Drivers:

  • Rising Diabetes Prevalence: The increasing global prevalence of diabetes is one of the primary drivers of the pen needles market. As the number of individuals diagnosed with diabetes continues to rise, the demand for insulin delivery devices like pen needles also increases.
  • Shift Towards Self-Administration: The trend toward self-administration of medications, particularly for chronic conditions like diabetes, has led to a greater demand for user-friendly and convenient delivery methods. Pen needles offer a simple and less intimidating way for patients to administer insulin injections on their own.

Market Segmentation:

Type of Pen Needles:

  • Standard Pen Needles: Traditional pen needles with a fixed length and gauge.
  • Safety Pen Needles: Pen needles with built-in safety features, such as needle shields or automatic retraction after use.
  • Nano and Micro Pen Needles: Ultra-fine pen needles designed for reduced pain and discomfort during injections.

Needle Length:

  • Short Pen Needles (4mm, 5mm): Suitable for individuals with lean body mass, as they reduce the risk of intramuscular injections.
  • Medium Pen Needles (6mm, 8mm): Often used for average body types.
  • Long Pen Needles (10mm, 12mm): Suitable for individuals with thicker subcutaneous tissue.

Needle Gauge (Thickness):

  • Higher Gauge (Thinner Needle): Offers reduced pain and discomfort during injection, suitable for patients with needle anxiety.
  • Lower Gauge (Thicker Needle): Preferred by some patients for perceived stability during injection.

End-user:

  • Hospitals and Clinics: Pen needles used in clinical settings by healthcare professionals for patient injections.
  • Home Healthcare: Pen needles intended for patients to self-administer insulin injections at home.
  • Retail Pharmacies: Pen needles available for purchase over the counter without a prescription.

Distribution Channel:

  • Retail Pharmacies: Pen needles available for direct purchase by consumers without a prescription.
  • Hospital Pharmacies: Pen needles distributed to hospitals and clinics for healthcare professional use.
  • Online Retail: Pen needles available for purchase through online platforms, offering convenience to patients.

Geographic Regions:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Procure Complete Report at 15% Discount (250 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/pen-needle-market

Regional Growth Dynamics:

North America held the highest market share in terms of revenue in 2022, accounting for around two-fifths of the global pen needles market revenue and is likely to dominate the market during the forecast period. The growth is attributed to the well-developed healthcare infrastructure, rise in awareness among consumers about advancements in needle technology, and surge in demand for injector pens with subsequent rise in demand for pen needles in this region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 11.2% from 2023 to 2032, owing to large population base in countries such as China and India, rising healthcare expenditure, and developing healthcare infrastructure in this region

Competitive Landscape:

  • Allison Medical Inc. 
  • B. Braun SE 
  • Novo Nordisk A/S 
  • Owen Mumford Ltd. 
  • Terumo Corporation 
  • Trividia Health, Inc. 
  • Ultimed, Inc. 
  • Ypsomed AG 

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/3581

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level.
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com 

Leave a comment

Your email address will not be published. Required fields are marked *